Abstract
A recent study that applied new criteria for diagnosing neuromyelitis optica spectrum disorders in the absence of serum aquaporin 4 antibodies highlights difficulties with clinical application of these criteria. Classification on the basis of molecular markers might offer a more practical alternative.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
